VivoSim Labs
VIVS
109 hedge funds and large institutions have $37.4M invested in VivoSim Labs in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 12 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 26
0.02% less ownership
Funds ownership: 0.1% → 0.08% (-0.02%)
3% less funds holding
Funds holding: 112 → 109 (-3)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
30% less capital invested
Capital invested by funds: $53.5M → $37.4M (-$16.1M)
78% less call options, than puts
Call options by funds: $410K | Put options by funds: $1.88M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$426K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$372K |
| 3 |
D.E. Shaw & Co
New York
|
+$186K |
| 4 |
Citigroup
New York
|
+$110K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$95.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Think Investments
San Francisco,
California
|
-$3.44M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.73M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.11M |
| 4 |
Goldman Sachs
New York
|
-$797K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$290K |
VIVS Hedge Fund Activity: Q1 2016 in Review
109 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2016, worth a combined $37.4M — down 30% from $53.5M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of VIVS and 10 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 37 added.
The largest buyer was State Street, adding an estimated $426K. The largest seller was Think Investments, exiting entirely with an estimated $3.44M sold.
- 109 institutional investors held VivoSim Labs (VIVS) as of Q1 2016, down from 112 in Q4 2015.
- Funds reported $37.4M of VivoSim Labs stock for Q1 2016, down 30% quarter-over-quarter.
- 10 funds opened new VivoSim Labs positions in Q1 2016 and 12 closed out, a net change of -2 holders.
- The largest VivoSim Labs buyer in Q1 2016 was State Street, an estimated $426K added.
- The largest VivoSim Labs seller in Q1 2016 was Think Investments, an estimated $3.44M sold.
Based on aggregated 13F filings for Q1 2016.